Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation
L. Prince, S. Renshaw, A. Rahman, K. M. Henry, K. Herman, A. A. R. Thompson, H. Isles, C. Tulotta, D. Sammut, J. Rougeot, N. Khoshaein, A. Reese, K. Higgins, C. Tabor, I. Sabroe, , D. Dockrell
The paper identifies ErbB kinase inhibitors as potential therapies for neutrophilic inflammation by showing they accelerate neutrophil apoptosis in multiple models.
bioRxiv · Aug 19, 2019Immunology